ASCO GU 2026: Updates in metastatic prostate cancer
The session discusses the debate over office-based cystoscopy and the preference for contrast-enhanced CT. Imaging techniques, including MRI and CT scans, play significant roles in diagnosis, while molecular profiling has limited initial treatment applications. A case of a large bladder tumour highlights management complexities.
ASCO GU 2026: Updates in metastatic prostate cancer
ASCO GU 2026: Updates in localised prostate cancer
Empowering cancer care in Africa
Do all hormone sensitive prostate cancers need triplet therapy?
Choosing Wisely for genitourinary cancers
Prostate cancer
Enhancing patient care through pharmacovigilance
Strengthening comprehensive cancer program and monitoring in Indonesia by tele-mentoring ECHO
Gaza's cancer patients: Navigating the dual struggle of illness and war